Viewing Study NCT01606566


Ignite Creation Date: 2025-12-24 @ 4:27 PM
Ignite Modification Date: 2026-01-03 @ 8:10 AM
Study NCT ID: NCT01606566
Status: TERMINATED
Last Update Posted: 2022-02-18
First Post: 2012-05-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Safety and Efficacy of Amphinex Induced PCI of Bleomycin for Recurrent Head and Neck Cancer.
Sponsor: PCI Biotech AS
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: PCIA202/10
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators